Condensed Consolidated Statements of Redeemable Convertible Preferred Stock, Warrants to Placement Agent and Shareholders' Equity (Unaudited) - USD ($)  $ in Thousands  | 
 Previously Reported  
Redeemable Convertible Preferred Stock 
 | 
 Previously Reported  
Common Stock 
 | 
 Previously Reported  
Non-voting Common Stock 
 | 
 Previously Reported  
Additional paid-in capital 
 | 
 Previously Reported  
Accumulated deficit 
 | 
Previously Reported  | 
Redeemable Convertible Preferred Stock  | 
Common Stock  | 
Non-voting Common Stock  | 
Additional paid-in capital  | 
Accumulated deficit  | 
Warrants To Placement Agent  | 
Total  | 
| Balance at Dec. 31, 2020 | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
$ 5,585
 | 
 | 
 
 | 
[1] | 
 
 | 
[1] | 
$ 2,771
 | 
 | 
$ (17,169)
 | 
 
 | 
$ (14,398)
 | 
 | 
| Balance (in Shares) at Dec. 31, 2020 | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
7,731,083
 | 
 | 
2,047,641
 | 
 | 
1,783,773
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Exercise of options into common stock | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 
 | 
 
 | 
[1] | 
| Exercise of options into common stock (in Shares) | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
2,763
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Share based compensation | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
53
 | 
 | 
 
 | 
 
 | 
53
 | 
 | 
| Net comprehensive loss for the period | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
(5,251)
 | 
 
 | 
(5,251)
 | 
 | 
| Balance at Dec. 31, 2021 | 
 | 
$ 5,585
 | 
 
 | 
[1] | 
 
 | 
[1] | 
$ 2,824
 | 
$ (22,420)
 | 
$ (19,596)
 | 
$ 5,585
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
2,824
 | 
 | 
(22,420)
 | 
 
 | 
(19,596)
 | 
 | 
| Balance (in Shares) at Dec. 31, 2021 | 
 | 
7,731,083
 | 
2,050,404
 | 
 | 
1,783,773
 | 
 | 
 
 | 
 
 | 
 
 | 
773,108
 | 
[2] | 
205,040
 | 
[2] | 
178,377
 | 
[2] | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Exercise of options into common stock | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 
 | 
 
 | 
[1] | 
| Exercise of options into common stock (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
1,546
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Share based compensation | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
14
 | 
 | 
 
 | 
 
 | 
14
 | 
 | 
| Share based compensation (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Net comprehensive loss for the period | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
(4,639)
 | 
 
 | 
(4,639)
 | 
 | 
| Balance at Mar. 31, 2022 | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
$ 5,585
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
2,838
 | 
 | 
(27,059)
 | 
 
 | 
(24,221)
 | 
 | 
| Balance (in Shares) at Mar. 31, 2022 | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
773,108
 | 
 | 
206,586
 | 
 | 
178,377
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Balance at Dec. 31, 2021 | 
 | 
$ 5,585
 | 
 
 | 
[1] | 
 
 | 
[1] | 
2,824
 | 
(22,420)
 | 
(19,596)
 | 
$ 5,585
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
2,824
 | 
 | 
(22,420)
 | 
 
 | 
(19,596)
 | 
 | 
| Balance (in Shares) at Dec. 31, 2021 | 
 | 
7,731,083
 | 
2,050,404
 | 
 | 
1,783,773
 | 
 | 
 
 | 
 
 | 
 
 | 
773,108
 | 
[2] | 
205,040
 | 
[2] | 
178,377
 | 
[2] | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Net comprehensive loss for the period | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
(8,500)
 | 
 | 
| Balance at Sep. 30, 2022 | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 1
 | 
 | 
 
 | 
 | 
36,482
 | 
 | 
(30,920)
 | 
 
 | 
5,563
 | 
 | 
| Balance (in Shares) at Sep. 30, 2022 | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
1,731,755
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Balance at Dec. 31, 2021 | 
 | 
$ 5,585
 | 
 
 | 
[1] | 
 
 | 
[1] | 
2,824
 | 
(22,420)
 | 
(19,596)
 | 
$ 5,585
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
2,824
 | 
 | 
(22,420)
 | 
 
 | 
(19,596)
 | 
 | 
| Balance (in Shares) at Dec. 31, 2021 | 
 | 
7,731,083
 | 
2,050,404
 | 
 | 
1,783,773
 | 
 | 
 
 | 
 
 | 
 
 | 
773,108
 | 
[2] | 
205,040
 | 
[2] | 
178,377
 | 
[2] | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Exercise of options into common stock | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
5
 | 
 | 
 
 | 
 
 | 
5
 | 
 | 
| Exercise of options into common stock (in Shares) | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
77,749
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Share based compensation | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
220
 | 
 | 
 
 | 
 
 | 
220
 | 
 | 
| Conversion of convertible redeemable preferred stock to common stock upon initial public offering | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
$ (5,585)
 | 
 | 
$ 1
 | 
 | 
 
 | 
 | 
5,584
 | 
 | 
 
 | 
 
 | 
5,585
 | 
 | 
| Conversion of convertible redeemable preferred stock to common stock upon initial public offering (in Shares) | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
(7,731,083)
 | 
 | 
7,731,083
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions and other offering costs | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
14,675
 | 
 | 
 
 | 
 
 | 
14,675
 | 
 | 
| Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions and other offering costs (in Shares) | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
4,212,500
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Conversion of convertible loan to common stock upon initial public offering | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
6,553
 | 
 | 
 
 | 
 
 | 
6,553
 | 
 | 
| Conversion of convertible loan to common stock upon initial public offering (in Shares) | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
1,638,161
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Conversion of convertible note to common stock upon initial public offering | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
3,600
 | 
 | 
 
 | 
 
 | 
3,600
 | 
 | 
| Conversion of convertible note to common stock upon initial public offering (in Shares) | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
900,096
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Conversion of warrants to common stock upon initial public offering | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
3,190
 | 
 | 
 
 | 
 
 | 
3,190
 | 
 | 
| Conversion of warrants to common stock upon initial public offering (in Shares) | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
797,567
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Redemption of non-voting common stock upon initial public offering | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
[1] | 
| Redemption of non-voting common stock upon initial public offering (in Shares) | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
(1,783,773)
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Repurchase of common stock | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
15
 | 
 | 
 
 | 
 
 | 
15
 | 
 | 
| Repurchase of common stock (in Shares) | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
(27,699)
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Net comprehensive loss for the period | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
(10,982)
 | 
 
 | 
(10,982)
 | 
 | 
| Balance at Dec. 31, 2022 | 
 | 
 
 | 
$ 1
 | 
 | 
 
 | 
 | 
36,666
 | 
(33,402)
 | 
3,265
 | 
 
 | 
 | 
$ 1
 | 
 | 
 
 | 
 | 
36,666
 | 
 | 
(33,402)
 | 
 
 | 
3,265
 | 
 | 
| Balance (in Shares) at Dec. 31, 2022 | 
 | 
 
 | 
17,379,861
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
[2] | 
1,737,986
 | 
[2] | 
 
 | 
[2] | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Balance at Mar. 31, 2022 | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
$ 5,585
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
2,838
 | 
 | 
(27,059)
 | 
 
 | 
(24,221)
 | 
 | 
| Balance (in Shares) at Mar. 31, 2022 | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
773,108
 | 
 | 
206,586
 | 
 | 
178,377
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Share based compensation | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
14
 | 
 | 
 
 | 
 
 | 
14
 | 
 | 
| Share based compensation (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Conversion of convertible preferred stock to common stock upon initial public offering | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
$ (5,585)
 | 
 | 
$ 1
 | 
 | 
 
 | 
 | 
5,584
 | 
 | 
 
 | 
 
 | 
5,585
 | 
 | 
| Conversion of convertible preferred stock to common stock upon initial public offering (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
(773,108)
 | 
 | 
773,108
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions and other offering costs | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
14,675
 | 
 | 
 
 | 
 
 | 
14,675
 | 
 | 
| Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions and other offering costs (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
421,250
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Conversion of convertible loan to common stock upon initial public offering | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
6,553
 | 
 | 
 
 | 
 
 | 
6,553
 | 
 | 
| Conversion of convertible loan to common stock upon initial public offering (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
163,816
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Conversion of convertible note to common stock upon initial public offering | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
3,600
 | 
 | 
 
 | 
 
 | 
3,600
 | 
 | 
| Conversion of convertible note to common stock upon initial public offering (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
90,009
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Conversion of warrants to common stock upon initial public offering | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
3,190
 | 
 | 
 
 | 
 
 | 
3,190
 | 
 | 
| Conversion of warrants to common stock upon initial public offering (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
79,756
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Redemption of non-voting common stock upon initial public offering | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
[1] | 
| Redemption of non-voting common stock upon initial public offering (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
(178,377)
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Repurchase of common stock | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
15
 | 
 | 
 
 | 
 
 | 
15
 | 
 | 
| Repurchase of common stock (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
(2,770)
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Net comprehensive loss for the period | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
(1,654)
 | 
 
 | 
(1,654)
 | 
 | 
| Balance at Jun. 30, 2022 | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 1
 | 
 | 
 
 | 
 | 
36,469
 | 
 | 
(28,713)
 | 
 
 | 
7,757
 | 
 | 
| Balance (in Shares) at Jun. 30, 2022 | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
1,731,755
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Share based compensation | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
13
 | 
 | 
 
 | 
 
 | 
13
 | 
 | 
| Share based compensation (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Net comprehensive loss for the period | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
(2,207)
 | 
 
 | 
(2,207)
 | 
 | 
| Net comprehensive loss for the period (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Balance at Sep. 30, 2022 | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 1
 | 
 | 
 
 | 
 | 
36,482
 | 
 | 
(30,920)
 | 
 
 | 
5,563
 | 
 | 
| Balance (in Shares) at Sep. 30, 2022 | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
1,731,755
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Balance at Dec. 31, 2022 | 
 | 
 
 | 
$ 1
 | 
 | 
 
 | 
 | 
36,666
 | 
(33,402)
 | 
3,265
 | 
 
 | 
 | 
$ 1
 | 
 | 
 
 | 
 | 
36,666
 | 
 | 
(33,402)
 | 
 
 | 
3,265
 | 
 | 
| Balance (in Shares) at Dec. 31, 2022 | 
 | 
 
 | 
17,379,861
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
[2] | 
1,737,986
 | 
[2] | 
 
 | 
[2] | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Share based compensation | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
95
 | 
 | 
 
 | 
 
 | 
95
 | 
 | 
| Share based compensation (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Repurchase of common stock | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
(50)
 | 
 | 
 
 | 
 
 | 
(50)
 | 
 | 
| Repurchase of common stock (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
(7,920)
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Net comprehensive loss for the period | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
(1,895)
 | 
 
 | 
(1,895)
 | 
 | 
| Net comprehensive loss for the period (in Shares) | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Balance at Mar. 31, 2023 | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 1
 | 
 | 
 
 | 
 | 
36,711
 | 
 | 
(35,297)
 | 
 
 | 
1,415
 | 
 | 
| Balance (in Shares) at Mar. 31, 2023 | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
1,730,066
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Balance at Dec. 31, 2022 | 
 | 
 
 | 
$ 1
 | 
 | 
 
 | 
 | 
$ 36,666
 | 
$ (33,402)
 | 
$ 3,265
 | 
 
 | 
 | 
$ 1
 | 
 | 
 
 | 
 | 
36,666
 | 
 | 
(33,402)
 | 
 
 | 
3,265
 | 
 | 
| Balance (in Shares) at Dec. 31, 2022 | 
 | 
 
 | 
17,379,861
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
[2] | 
1,737,986
 | 
[2] | 
 
 | 
[2] | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Net comprehensive loss for the period | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
(4,355)
 | 
 | 
| Balance at Sep. 30, 2023 | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 1
 | 
 | 
 
 | 
 | 
38,594
 | 
 | 
(37,757)
 | 
104
 | 
838
 | 
 | 
| Balance (in Shares) at Sep. 30, 2023 | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
2,694,179
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Balance at Mar. 31, 2023 | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 1
 | 
 | 
 
 | 
 | 
36,711
 | 
 | 
(35,297)
 | 
 
 | 
1,415
 | 
 | 
| Balance (in Shares) at Mar. 31, 2023 | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
1,730,066
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Exercise of options into common stock | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
10
 | 
 | 
 
 | 
 
 | 
10
 | 
 | 
| Exercise of options into common stock (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
10,652
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Share based compensation | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
97
 | 
 | 
 
 | 
 
 | 
97
 | 
 | 
| Share based compensation (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Issuance of common stock and pre-funded warrants upon private placement, net of underwriting commissions and other offering costs | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
1,356
 | 
 | 
 
 | 
104
 | 
1,356
 | 
 | 
| Issuance of common stock and pre-funded warrants upon private placement, net of underwriting commissions and other offering costs (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
190,000
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Net comprehensive loss for the period | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
(1,593)
 | 
 
 | 
(1,593)
 | 
 | 
| Net comprehensive loss for the period (in Shares) | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Balance at Jun. 30, 2023 | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 1
 | 
 | 
 
 | 
 | 
38,174
 | 
 | 
(36,890)
 | 
104
 | 
1,285
 | 
 | 
| Balance (in Shares) at Jun. 30, 2023 | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
1,930,718
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Exercise of options into common stock | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 
 | 
 
 | 
[1] | 
| Exercise of options into common stock (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
8,791
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Share based compensation | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
106
 | 
 | 
 
 | 
 
 | 
106
 | 
 | 
| Share based compensation (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Exercise of pre-funded warrants into common stock | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 | 
 
 | 
[1] | 
 
 | 
 
 | 
 
 | 
[1] | 
| Exercise of pre-funded warrants into common stock (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
754,670
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Reclassification of warrants from liabilities to equity (see note (11(d)) | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
314
 | 
 | 
 
 | 
 
 | 
314
 | 
 | 
| Reclassification of warrants from liabilities to equity (see note (11(d)) (in Shares) | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Net comprehensive loss for the period | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
(867)
 | 
 
 | 
(867)
 | 
 | 
| Net comprehensive loss for the period (in Shares) | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
| Balance at Sep. 30, 2023 | 
 | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
$ 1
 | 
 | 
 
 | 
 | 
$ 38,594
 | 
 | 
$ (37,757)
 | 
$ 104
 | 
$ 838
 | 
 | 
| Balance (in Shares) at Sep. 30, 2023 | 
[2] | 
 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
2,694,179
 | 
 | 
 
 | 
 | 
 
 | 
 | 
 
 | 
 
 | 
 
 | 
 | 
 | 
 |